Jeffrey Miller

Company: University of Minnesota

Job title: Professor of Medicine

Seminars:

Developing iPSCs as an ‘Infinite’, Pre-Engineered Cell Source for Consistent, Scalable, ‘Off-the-Shelf’ Innate Killer Therapies 9:30 am

Considering if iPSCs are good cell products, the desirable attributes conferred, and future improvements to be made Describing the persistence of iPSC derived cells and early clinical responses Reviewing the manufacturing challenges, advantages, and considerations for iPSC-derived NK cell therapies such as batchto-batch variability, engineering steps, safety data, and scalability Discussing pre-clinical plans to target…Read more

day: Day One